Skip to content
GenoLensGenoLens

MYLK2

Chr 20q11.21

myosin light chain kinase 2

Aliases:
skMLCK, KMLC, MLCK2
MANE:
ENST00000375985.5

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Hypertrophic cardiomyopathy

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Thoracic aortic aneurysm or dissection

  • Thoracic aortic aneurysm or dissection (GMS)

  • Sudden death in young people

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • familial hypertrophic cardiomyopathy

    0.57
  • hypertrophic cardiomyopathy 1

    0.52
  • cardiomyopathy

    0.34
  • Rare familial disorder with hypertrophic cardiomyopathy

    0.21
  • hypertrophic cardiomyopathy

    0.18
  • ventricular tachycardia

    0.12
  • Left ventricular noncompaction cardiomyopathy

    0.12
  • dilated cardiomyopathy 1KK

    0.12
  • Parkinson disease

    0.11
  • Angiokeratoma corporis diffusum

    0.11

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Myosin light chain kinase 2, skeletal/cardiac muscle

Ca(2+)/calmodulin-dependent kinase that phosphorylates the regulatory light chain (RLC) of sarcomeric myosin in skeletal and cardiac muscle. Phosphorylation of RLC promotes displacement of myosin cross-bridges from the thick filament backbone toward actin-containing thin filaments, increasing the probability of cross-bridge entry into force-generating states and thereby potentiating contractile force at submaximal Ca(2+) concentrations

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.